The aim of the present study was to investigate the expression of mRNA and protein for inducible nitric oxide synthase (iNOS) in human cultured endometrial stromal cells. The endometrial stromal cells were cultured in the absence or the presence of cytokines such as interleukin (IL)-1β and interferon (IFN)-γ, which are inherently detectable in the endometrium. Nested reverse transcription-polymerase chain reaction detected iNOS mRNA in stromal cells cultured without cytokines. Northern blot analysis failed to detect iNOS mRNA in stromal cells cultured for 9 h in the absence of cytokines or in the presence of IL-1β (10-100 ng/ml) or IFN-γ (10-1000 U/ml) alone, but could detect iNOS mRNA cultured in combinations of IL-1β and IFN-γ. The concentrations of iNOS mRNA were increased as early as 3 h after the addition of the cytokine combination and persisted for up to 36 h. Western blot analysis demonstrated iNOS protein in stromal cells cultured for 12 h with combined IL-1β and IFN-γ. These results raise the possibility that nitric oxide locally synthesized by iNOS may be involved in the control of endometrial functions.
Introduction
Nitric oxide (NO), one of the smallest and simplest biosynthetic products, is a free radical gas which acts especially within the vascular system (Palmer et al., 1987) . It is also recognized that NO is generated by many cell types and is involved in diverse functions, including the regulation of vascular tone, neurotransmission and mediation of immune response (Nathan, 1992) . This signalling molecule is therefore likely to have an important role within the endometrium which shows changes in vascular function throughout the course of the menstrual cycle and at the time of implantation.
NO is made by conversion of L-arginine to L-citrulline catalysed by a family of enzymes known as nitric oxide synthases (NOSs) (Moncada et al., 1991) . NOS isoforms are categorized into three types, i.e. neuronal (n) NOS, endothelial (e) NOS and inducible (i) NOS. nNOS, originally identified in neuronal tissues, is expressed constitutively and is calciumdependent, similar to eNOS, which was first identified as a constitutive enzyme in vascular endothelial cells. On the other hand, iNOS, which is not dependent on calcium concentrations, has been shown to be expressed in a wide array of tissues and organs, and can be induced by cytokines such as interleukin (IL)-1β, interferon (IFN)-γ and tumour necrosis factor (TNF)-α or endotoxins such as bacterial lipopolysaccharide (LPS) (Förstermann et al., 1995) . Inducible NOS is normally absent from cells under resting conditions, but when stimulated by cytokines or LPS, it can produce large quantities of NO (nanomoles), while the other two constitutive isoforms produce small amounts of NO (picomoles) for short periods (Berdeaux, 1993) .
The production of NO in the endometrium has not been widely addressed. Using immunohistochemistry, nNOS protein has been detected in endometrial epithelium in the rat (Schmidt et al., 1992) and iNOS in the mouse (Huang et al., 1995) . There has been a previous study in humans that showed protein and mRNA for eNOS detected in endometrial glandular epithelium and stroma by in-situ hybridization and immunocytochemistry (Telfer et al., 1995) . Moreover, eNOS mRNA has been shown in human epithelial glands throughout the menstrual cycle by Northern blot analysis, whilst the expression of iNOS mRNA has been detected only in the epithelial glands of a menstrual endometrium by solution hybridization/ ribonuclease protection assay (Tseng et al., 1996) . In addition, recent work has reported that protein and mRNA for eNOS and iNOS were detected in human endometrial glandular epithelium but not found in endometrial stroma by immunocytochemistry and reverse transcription-polymerase chain reaction (RT-PCR) . Thus the role of NOS in the control of endometrial functions has not been fully understood.
The aim of the present study was to detect the presence of iNOS mRNA in human cultured endometrial stromal cells by RT-PCR. We further examined whether mRNA and protein for iNOS could be induced in cultured stromal cells by two kinds of cytokines, which are inherently present in the endometrium, using Northern blot and Western blot analysis. 
Tissue collection
Human endometrial tissues in the secretory phase were obtained from premenopausal women with regular menstrual cycles undergoing hysterectomy for benign diseases at the Tokyo Medical and Dental University Hospital, Japan. The stage of the cycle was determined by the date of the last menstrual period. With the informed consent of each woman, all of the sampling and using of these tissues for this study were approved by the local ethics committee. All the patients had no prior hormonal drug treatment and were otherwise healthy. Endometrial tissue was scraped from the uterine wall with scissors and pincette immediately after hysterectomy, thoroughly washed with physiological saline, placed in cold RPMI 1640 medium without FBS, and rapidly transported to the laboratory.
Isolation of endometrial stromal cells and cell culture
The specimen was washed three times with RPMI 1640 medium to eliminate blood clots and then cut into multiple pieces. According to the methods described previously (Satyaswaroop et al., 1979) , tissue pieces were treated with 2 mg/ml collagenase and 50 µg/ml deoxyribonuclease in D-PBS and digested at 37°C for 1 h. The digested endometrial cells were filtrated through 38 µm steel mesh to remove cell debris and epithelial gland fragments, and washed with D-PBS supplemented with 2 mM EDTA and 0.5% BSA three times. To remove macrophages/monocytes, the cells were treated with MicroBeads conjugated with monoclonal anti-human CD14 antibodies (Miltenyi Biotec, Bergisch Gladbach, Germany), followed by Magnetic Cell Sorting depletion column chromatography according to the manufacturer's instructions (Miltenyi Biotec). The number of viable endometrial cells was counted by Trypan Blue exclusion. Viable cells were seeded onto 100 mm plastic culture dishes (Falcon, Rockford, IL, USA) at a density of 5ϫ10 6 cells/dish in 5 ml of RPMI 1640 medium containing 10% FBS and antibiotics. The medium was removed 2 h later, and adherent cells were washed with fresh medium. Quick attachment of stromal cells selectively removed blood cell contamination, and cells were cultured in a humidified atmosphere of 5% CO 2 in 95% air at 37°C. Cultured cells were used for experiments when 70% confluence was achieved. On the day of the experiment, microscopic inspection revealed that almost all cultured cells were stromal/fibroblast-like cells in appearance without epithelial contamination. This result was immunocytochemically confirmed by positive staining with anti-vimentin antibody and not with anti-cytokeratin antibody. The medium was removed, endometrial stromal cells were washed and treated with various concentrations of the following cytokines; IL-1β (10-100 ng/ml) and IFN-γ (10-1000 U/ml). They were maintained for various periods up to 36 h.
RNA extraction and nested RT-PCR
Total RNA was isolated from cultured cells by the single step acid guanidinium thiocyanate-phenol-chloroform extraction method (Chomczynski and Sacchi, 1987) . Complementary DNA synthesis was carried out on 1 µg of total RNA as follows: RNA dissolved in sterile DEPC-treated water was heated to 80°C with 50 ng of random hexanucleotide primers (Takara, Otsu, Japan) for 5 min, then added to a total volume of 20 µl of reaction mixture containing 50 mM Tris-HCl (pH 8.3), 40 mM KCl, 5 mM MgCl 2 , 0.5% Tween-20 (v/v), 10 mM DTT, 1 mM each dNTP, 20 units of ribonuclease inhibitor (Boehringer Mannheim, Mannheim, Germany) and 50 units of reverse transcriptase (Boehringer Mannheim). After incubation at 42°C for 1 h, one-fifth (4 µl) of the RT reacted mixture was used as template for PCR. PCR amplification was then carried out with the primers for human iNOS which spanned exons 22-26 (Geller et al., 1993) ; 5Ј-TGTCTGCAGCACATGGCTCAACAG-3Ј (3032-3055) and 5Ј-CTCAGATAATGCAGAGCTGGCTCC-3Ј (3737-3714) in a total volume of 20 µl of PCR solution containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 2 mM MgCl 2 , 0.2 mM each dNTP, 0.5 µM each primer described above and 0.5 units of Ex Taq polymerase (Takara) for 30 cycles (94°C for 30 s, 55°C for 60 s and 72°C for 60 s) in a Perkin-Elmer GeneAmp 2400 Thermal Cycler (Foster City, CA, USA). In an attempt to increase the sensitivity for the detection of iNOS transcript, cDNA obtained was assayed by a nested PCR method. For this reason, second PCR amplification was undertaken with the inner primers which spanned exons 23-26 (Geller et al., 1993) ; 5Ј-ATCCCTCCCATCCTTGCATCCTCAT-3Ј (3121-3145) and 5Ј-CTGTCCTTCTTCGCCTCGTAAGGAA-3Ј (3625-3601), and one-tenth (2 µl) of the first amplified cDNA as template. The reaction was carried out in a cycle profile of 30 s at 94°C, 60 s at 65°C and 60 s at 72°C for 30 cycles. Amplified product was analysed by 1.5% agarose gel electrophoresis and ethidium bromide staining. The PCR product was gel-purified using a QIAEX II kit (Qiagen, Hilden, Germany) and isolated cDNA was cloned into pGEM-T vector according to the instructions provided by the manufacturer (Promega, Madison, WI, USA). The sequence of the cloned cDNA was analysed with an automated ABI PRISM 310 sequencer (Perkin-Elmer).
Northern blot analysis
Cloned cDNA fragment containing 505 bp of human iNOS-specific sequence was used as a probe for Northern blot analysis. Twenty µg of total cellular RNA was denatured and subjected to electrophoresis in 1% agarose/5.4% formaldehyde gel in 1ϫMOPS buffer (20 mM MOPS, 50 µM sodium acetate, 1 mM EDTA, pH 7.0). The RNAs were transferred onto a Biodyne A membrane (Pall, Glen Cove, NY, USA) and immobilized by UV cross-linking. Hybridization was carried out with a 25 ng 32 P-labelled probe in QuikHyb Hybridization Solution (Stratagene, La Jolla, CA, USA) at 68°C for 1 h. The membrane was washed initially with 2ϫstandard saline citrate (SSC; 1ϫSSC ϭ 150 mM NaCl, 15 mM sodium citrate)/0.1% sodium dodecyl sulphate (SDS) at room temperature for 15 min twice, followed by increasing stringency up to 0.1ϫSSC/0.1% SDS at 60°C for 30 min and exposed to an imaging plate (Fuji Photo Film Co., Japan). The relative intensities of Northern blot hybridization signals were determined using a Bio-imaging analyser BAS2000 (Fuji Photo Film Co.).
Western blot analysis
The cultured stromal cells were fixed with 10% trichloroacetic acid in D-PBS and lysed with 20 µl of lysis buffer (9 M urea/2% Triton X-100/1% DTT), then supplemented with 5 µl of 10% LiDS. The concentration of protein in lysates was measured with a BCA protein assay kit (Pierce, Rockford, IL, USA). Each sample containing equivalent amount of protein was separated on 7.5% SDS-polyacrylamide gel electrophoresis and then transferred onto a polyvinylidene difluoride membrane (Atto, Tokyo, Japan). After blocking with Block Ace (Dainippon, Osaka, Japan), the membrane was incubated with an affinity column-purified anti-human iNOS polyclonal antibody (1:1000) raised against amino acids 1135-1153 (Santa Cruz, Heidelberg, Germany), followed by incubation with a horseradish peroxidase conjugated anti-rabbit IgG antibody (1:3000) (Amersham, Buckinghamshire, UK). The bound antibody was detected by the enhanced Figure 1 . Nested reverse transcription-polymerase chain reaction for iNOS (inducible nitric oxide synthase) using total RNA extracted from human endometrial stromal cells cultured without cytokines. A 505 bp polymerase chain reaction product was the size predicted based on the cDNA sequence of human iNOS. The amplified cDNA fragment was separated on a 1.5% agarose gel and visualized by ethidium bromide staining. chemiluminescence detection system according to the recommended procedure (Amersham).
Results

Detection of iNOS mRNA in endometrial stromal cells cultured without cytokines by nested RT-PCR
Messenger RNA for iNOS was detected by nested RT-PCR in total RNA extracted from human endometrial stromal cells cultured without cytokines. As shown in Figure 1 , nested RT-PCR for iNOS in cultured cells produced one intense band of the expected size and sequencing of the amplified product revealed 99% homology with the published sequence of human iNOS (Geller et al., 1993) .
Effect of cytokines on iNOS mRNA expression in cultured endometrial stromal cells
To examine whether iNOS mRNA was induced by cytokines in cultured endometrial stromal cells, total RNA extracted from cells was analysed by Northern blot hybridization. As shown in Figure 2 , iNOS mRNA was not detected in stromal cells cultured for 9 h in either the absence of cytokines or the presence of IL-1β or IFN-γ alone. However, combinations of IL-1β and IFN-γ increased the amount of iNOS mRNA in a dose-dependent manner on IFN-γ, and the expression reached its peak at a concentration of 10 ng/ml of IL-1β and 500 U/ml of IFN-γ. A prominent transcript of iNOS mRNA was~4.5 kilobases in length. Figure 3 shows the time-course of 10 ng/ml IL-1β and 500 U/ml IFN-γ stimulation for 0, 3, 6, 9, 12, 18, 24 and 36 h. The expression of iNOS mRNA began as early as 3 h after the addition of the cytokine combination and continued for up to 36 h.
Detection of iNOS protein by Western blot analysis
As shown in Figure 4 , iNOS protein was produced in stromal cells cultured for 12 h in the presence of 10 ng/ml of IL-1β and 500 U/ml of IFN-γ, but was undetectable when cells were incubated without cytokines. A 130 kD protein band was detected corresponding to the appropriate molecular weight 
Discussion
This study is the first to demonstrate the detection of iNOS mRNA by nested RT-PCR in human endometrial stromal cells cultured without cytokines. Although RT-PCR (not nested RT-PCR) detected iNOS mRNA in our preliminary studies, it produced a few non-specific bands (not shown). A previous study has already reported the detection of iNOS mRNA by RT-PCR in the epithelial cells of human endometrial gland fragments . The clear amplification obtained in epithelial cells but not in stromal cells by RT-PCR might be due to the levels of iNOS mRNA in each component of the endometrium or the different PCR conditions. From the Figure 4 . Western blot analysis of iNOS (inducible nitric oxide synthase) protein using an anti-human iNOS polyclonal antibody against proteins obtained from human cultured endometrial stromal cell lysates. The antibody reacted with a protein band at 130 kD (appropriate molecular weight for human iNOS protein), when stromal cells were cultured for 12 h with interleukin (IL)-1β (10 ng/ml) and interferon (IFN)-γ (500 U/ml).
previous and the present study, it is now concluded that endometrial iNOS mRNA is detectable in both epithelial and stromal cells.
Using Northern blot analysis, we have also been the first to demonstrate that a considerable amount of iNOS mRNA is expressed in stromal cells cultured in combinations of IL-1β and IFN-γ. However, no iNOS mRNA expression could be detected in either the absence of cytokines or the presence of either IL-1β or IFN-γ alone. It has been well established that iNOS is regulated mainly at the transcriptional level (Förstermann et al., 1995) . The structural similarity among the known human and murine promoter fragments contrasts with the different cytokine patterns required to induce human or murine iNOS (Nunokawa et al., 1994) . Therefore, the cytokines or the combinations of cytokines that produce significant iNOS expression vary between species or between cell types within the same species. For example, in rat reproductive organs, one report has shown that IL-1β alone stimulated iNOS mRNA expression in cultured Leydig cells (Tatsumi et al., 1997) . On the other hand, another study has demonstrated that Northern blot analysis failed to detect iNOS mRNA in granulosa cells cultured with a single cytokine, such as IL-1β, IFN-γ and TNF-α, but that the combinations of any two or three cytokines increased the amount of iNOS mRNA (Matsumi et al., 1998) . The present study has revealed that the combined administration of IL-1β and IFN-γ induces mRNA and protein for iNOS in human cultured endometrial stromal cells, with the expression beginning as early as 3 h and persisting for up to 36 h. Thus we conclude that iNOS in human endometrial stromal cells has few physiological functions in vivo but endometrial stromal cells have the ability to express mRNA and protein for iNOS in the presence of cytokines, which are inherently detectable in the endometrium especially in the secretory phase.
It has been previously reported that progesterone increased uterine NO formation during pregnancy in the rat (Yallampalli et al., 1994) , and recent work has revealed that antiprogestins 356 reduced iNOS protein in rat uterus (Dong et al., 1996) . There has been a previous study showing that immunoreactive iNOS was no longer detectable in the epithelial cells in the uterus of ovariectomized mice following treatment with 17β-oestradiol, but that weak staining of iNOS was observed in the epithelium as a consequence of progesterone treatment (Huang et al., 1995) . These findings suggest that iNOS activity in vivo is closely related to hormonal regulation (mainly progesterone) as well as cytokine stimulation. Furthermore, one report has shown that the pregnant rat uterus served as a source of NO that acted as an autocrine mediator in maintaining the quiescence necessary for normal fetal development, with iNOS appearing to be the major isoform involved in NO production (Dong et al., 1996) , and another has demonstrated that early in the pregnancy the iNOS amount was considerably increased by the presence of rat placental iNOS and that its expression was down-regulated prior to term, to reach very low values during delivery (Purcell et al., 1997) . However, there has been a study in human uterus and placenta that showed no difference in either the expression or enzyme activity of iNOS before and during labour at term, because iNOS may be already down-regulated near term (Thomson et al., 1997) .
We have demonstrated that a certain combination of cytokines induced mRNA and protein for iNOS in human cultured endometrial stromal cells. Telfer et al. (1997) have shown that immunoreactivity for iNOS was not present in human endometrial stroma throughout the menstrual cycle, but that iNOS-like immunoreactivity was seen in decidualized stromal cells following treatment with exogenous progestogen and in tissues obtained in the first trimester of pregnancy. The mechanisms by which decidualization in vivo causes stromal cells to express iNOS protein appear to be associated with exposure of cells to progesterone and various cytokines, because decidua in the early pregnancy expresses a high concentration of cytokines (Saito et al., 1993) . Our results indicate that stromal cells in the secretory phase have the potential to express iNOS in the presence of cytokines before decidualization. Therefore, because the proportion of leukocytes in human endometrial stroma increases dramatically in the late secretory phase and in the early pregnancy (Bulmer et al., 1991) , there is a possibility of iNOS expression in stromal cells locally around blood vessels in the late secretory phase under the stimulation by cytokines derived from infiltrating cells, such as macrophages and natural killer cells. Thus the expression of iNOS may have the advantage of permitting the integration of NO production into the complex networks required for the initiation of successful implantation and placentation (Norman and Cameron, 1996) .
What is the effect of NO on successful pregnancy? Nitric oxide is usually viewed as a very short-acting substance that is synthesized within close proximity to the site of its activity. Its half-life is only a few seconds. However, it is known that NO can rapidly diffuse to distances of 200-400 µm within tissues (Lancaster, 1994) . This is well within the range for stromal NO to act on the vascular bed. Therefore, NO produced by iNOS may be involved in controlling the development of the microvascular system and vascular tone in the endometrium in the secretory phase and in the early pregnancy.
